Sign in
4/A

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000034

Options or other derivatives

  • President and CEO acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ahn Mark J President and CEO 2013-11-26 Grant or award · Stock Option (right to buy) +600,000 600,000 D
Loading xslF345X03/primary_doc.xml…